Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta158
6 Recommendations for further research
6.1 Research is required into methods of delivering zanamivir to the under-5 age group and to establish the effectiveness of such treatment.
6.2 Research is required to develop options for prophylaxis of influenza in infants (under 12 months of age).